Borrego-Ruiz Alejandro, Borrego Juan J
Departamento de Psicología Social y de las Organizaciones, Facultad de Psicología, UNED, Madrid, Spain.
Departamento de Microbiología, Universidad de Málaga, Málaga, Spain.
Prog Neuropsychopharmacol Biol Psychiatry. 2024 Jan 10;128:110861. doi: 10.1016/j.pnpbp.2023.110861. Epub 2023 Sep 9.
There is a lot of evidence establishing that nervous system development is related to the composition and functions of the gut microbiome. In addition, the central nervous system (CNS) controls the imbalance of the intestinal microbiota, constituting a bidirectional communication system. At present, various gut-brain crosstalk routes have been described, including immune, endocrine and neural circuits via the vagal pathway. Several empirical data have associated gut microbiota alterations (dysbiosis) with neuropsychiatric diseases, such as Alzheimer's disease, autism and Parkinson's disease, and with other psychological disorders, like anxiety and depression. Fecal microbiota transplantation (FMT) therapy has shown that the gut microbiota can transfer behavioral features to recipient animals, which provides strong evidence to establish a causal-effect relationship. Interventions, based on prebiotics, probiotics or synbiotics, have demonstrated an important influence of microbiota on neurological disorders by the synthesis of neuroactive compounds that interact with the nervous system and by the regulation of inflammatory and endocrine processes. Further research is needed to demonstrate the influence of gut microbiota dysbiosis on psychiatric and psychological disorders, and how microbiota-based interventions may be used as potential therapeutic tools.
有大量证据表明,神经系统发育与肠道微生物群的组成和功能有关。此外,中枢神经系统(CNS)控制着肠道微生物群的失衡,构成了一个双向通信系统。目前,已经描述了多种肠-脑相互作用途径,包括通过迷走神经途径的免疫、内分泌和神经回路。一些实证数据将肠道微生物群改变(生态失调)与神经精神疾病(如阿尔茨海默病、自闭症和帕金森病)以及其他心理障碍(如焦虑和抑郁)联系起来。粪便微生物群移植(FMT)疗法表明,肠道微生物群可以将行为特征传递给受体动物,这为建立因果关系提供了有力证据。基于益生元、益生菌或合生元的干预措施已证明,微生物群通过合成与神经系统相互作用的神经活性化合物以及调节炎症和内分泌过程,对神经系统疾病具有重要影响。需要进一步研究以证明肠道微生物群生态失调对精神和心理障碍的影响,以及基于微生物群的干预措施如何用作潜在的治疗工具。
Prog Neuropsychopharmacol Biol Psychiatry. 2024-1-10
Clin Microbiol Rev. 2022-1-19
Gut Microbes. 2023-12
Expert Rev Gastroenterol Hepatol. 2022-4
Prog Neuropsychopharmacol Biol Psychiatry. 2021-7-13
Naunyn Schmiedebergs Arch Pharmacol. 2023-11
Pharmacol Res. 2020-7
J Microbiol. 2018-2-28
Microbiome Res Rep. 2025-4-17
Gen Psychiatr. 2025-8-12
AIMS Microbiol. 2025-4-14
Life (Basel). 2025-5-22